midazolam and sb 203580

midazolam has been researched along with sb 203580 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akamatsu, S; Dohi, S; Kato, K; Kozawa, O; Suga, H; Takai, S; Tanabe, K1
Ghori, K; O'Driscoll, J; Shorten, G1

Other Studies

2 other study(ies) available for midazolam and sb 203580

ArticleYear
Midazolam suppresses thrombin-induced heat shock protein 27 phosphorylation through inhibition of p38 mitogen-activated protein kinase in cardiac myocytes.
    Journal of cellular biochemistry, 2005, Sep-01, Volume: 96, Issue:1

    Topics: Anesthetics, Intravenous; Animals; Heat-Shock Proteins; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Midazolam; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Thrombin

2005
The effect of midazolam on neutrophil mitogen-activated protein kinase.
    European journal of anaesthesiology, 2010, Volume: 27, Issue:6

    Topics: CD11b Antigen; CD18 Antigens; Enzyme Inhibitors; Humans; Hypnotics and Sedatives; Imidazoles; Midazolam; Neutrophils; p38 Mitogen-Activated Protein Kinases; Pyridines; Reperfusion Injury

2010